首页> 外文OA文献 >Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model
【2h】

Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model

机译:分次放疗中放疗对放射敏感性鼠肉瘤和放射耐受性腺癌肿瘤模型的放射增敏作用

摘要

Radiosensitizing Effect of Electrochemotherapy in a Fractionated Radiation Regimen in Radiosensitive Murine Sarcoma and Radioresistant Adenocarcinoma Tumor Model. Electrochemotherapy can potentiate the radiosensitizing effect of bleomycin, as shown in our previous studies. To bring this treatment closer to use in clinical practice, we evaluated the interaction between electrochemotherapy with bleomycin and single-dose or fractionated radiation in two murine tumor models with different histology and radiosensitivity. Radiosensitive sarcoma SA-1 and radioresistant adenocarcinoma CaNT subcutaneous tumors grown in A/J and CBA mice, respectively, were used. The anti-tumor effect and skin damage around the treated tumors were evaluated after electrochemotherapy with bleomycin alone or combined with single-dose radiation or a fractionated radiation regimen. The anti-tumor effectiveness of electrochemotherapy was more pronounced in SA-1 than CaNT tumors. In both tumor models, the tumor response to radiation was not significantly influenced by bleomycin alone or by electroporation alone. However, electrochemotherapy before the first tumor irradiation potentiated the response to a single-dose or fractionated radiation regimen in both tumors. For the fractionated radiation regimen, normal skin around the treated tumors was damaged fourfold less than for the single-dose regimen. Electrochemotherapy prior to single-dose irradiation induced more damage to the skin around the treated tumors and greater loss of body weight compared to other irradiated groups, whereas electrochemotherapy combined with the fractionated radiation regimen did not. Electrochemotherapy with low doses of bleomycin can also be used safely for radiosensitization of different types of tumors in a fractionated radiation regimen, resulting in a good anti-tumor effect and no major potentiating effect on radiation-induced skin damage. © 2009 by Radiation Research Society.
机译:在放射敏感性小鼠肉瘤和放射耐受性腺癌肿瘤模型的分级放射治疗方案中的电化学疗法的放射增敏作用。如我们先前的研究所示,电化学疗法可以增强博来霉素的放射增敏作用。为了使这种治疗更接近于在临床实践中使用,我们在两种具有不同组织学和放射敏感性的鼠类肿瘤模型中评估了博来霉素电化学疗法与单剂量或分次放射之间的相互作用。使用分别在A / J和CBA小鼠中生长的放射敏感性肉瘤SA-1和放射抗性腺癌CaNT皮下肿瘤。在单独使用博来霉素或与单剂量放疗或分次放疗方案联合使用电化学疗法后,评估了治疗肿瘤周围的抗肿瘤作用和皮肤损伤。与CaNT肿瘤相比,SA-1中电化学疗法的抗肿瘤效果更为显着。在两个肿瘤模型中,单独的博来霉素或单独的电穿孔都没有显着影响肿瘤对放射的反应。然而,在第一次肿瘤照射之前的电化学疗法在两种肿瘤中均增强了对单剂量或分次放射方案的反应。对于分级放射疗法,治疗肿瘤周围的正常皮肤受到的损害比单剂量疗法少四倍。与其他被照射组相比,单剂量照射前的电化学疗法对治疗的肿瘤周围的皮肤造成更大的损害,并且体重减轻更大,而电化学疗法与分级照射方案相结合则没有。低剂量博来霉素的电化学疗法也可以安全地用于分级放疗方案中对不同类型肿瘤的放射增敏作用,从而产生良好的抗肿瘤作用,并且对辐射诱发的皮肤损伤没有主要的增强作用。 ©2009年,辐射研究学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号